MOVING THE FIELD TOWARD MORE PATIENT-FOCUSED DRUG DEVELOPMENT
This is an effort to push for the use of patients quality of life endpoints in clinical trials. Anyone designing a clinical trial now should read this. It is a team effort of the Jumpstarting Brain Tumor Drug Development Coalition ( Accelerate Brain Cancer Cure (ABC2), Musella Foundation for Brain Tumor Research and Information, National Brain Tumor Society and the Society for Neuro-Oncology), led by David Arons of the NBTS
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://blog.braintumor.org/moving-the-field-toward-more-patient-focused-drug-development/?src=readmore&id=2326
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines